metastatic pancreatic cancer survival

KRAS protein structure illustration showing the molecular form of KRAS used to explain why the target was considered undruggable.

The Real Story of KRAS Drugs in Pancreatic Cancer Treatment

KRAS pancreatic cancer treatment just reached a turning point: drugs targeting the gene behind 90% of these tumors are now showing real benefit in trials.

No results